Description
GLP-1/GIP/Glucagon 30mg – Research-Grade Peptide for GLP-1, GIP, and Receptor Pathway Studies
Delivery: Laboratory Research-Grade, 30mg Vial
GLP-1 / GIP / Glucagon 30mg is a synthetic, research-grade peptide developed for laboratory investigations into GLP-1, GIP, and glucagon receptor signaling, receptor signalling pathways, and peptide biology research. It is commonly used in in vitro and ex vivo studies examining multi-receptor interactions, cellular signaling mechanisms, and receptor signalling.
This product is strictly intended for research purposes only and is not approved for human consumption, clinical, or veterinary use.
What Is GLP-1/GIP/Glucagon?
GLP-1/GIP/Glucagon is a synthetic peptide that acts on multiple receptors, including GLP-1, GIP, and glucagon receptors, in laboratory systems. In research settings, GLP-1/GIP/Glucagon is used to investigate:
• Peptide–receptor binding and signal transduction mechanisms
• Multi-receptor signaling pathways in cellular models
• Receptor pathway modulation at the molecular level
• Experimental peptide pharmacology and biology
• Dose-response, stability, and molecular mechanism studies
All applications are strictly non-clinical and limited to scientific research.
Research Applications of GLP-1/GIP/Glucagon
GLP-1/GIP/Glucagon 30mg is suitable for laboratory research, including:
• Multi-Receptor Signaling Studies – Analysis of GLP-1, GIP, and glucagon receptor interactions
• Receptor Pathway Research – Investigation of peptide effects on cellular energetics and energy regulation
• Peptide Pharmacology & Biology – Controlled studies of synthetic peptide activity in vitro or ex vivo
• Experimental Endocrine Models – Mechanistic exploration of hormone receptor-mediated signaling
• Dose-Response & Stability Studies – Laboratory evaluation of peptide kinetics, receptor binding, and activity
All uses are strictly limited to scientific research purposes only.
Product Specifications
• Peptide: GLP-1/GIP/Glucagon
• Concentration: 30mg per vial
• Grade: Research-Grade
• Storage: Store according to standard peptide laboratory protocols
The 30mg format provides flexibility for medium- to large-scale laboratory studies, dose-response trials, and multi-phase experiments.
Purity & Quality Assurance
ExoLabz peptides are manufactured under strict quality control standards. ExoLabz products undergo independent third-party verification to confirm identity, purity, and content. Results are published on this site.
Researchers may submit the peptide for independent verification. If specifications are not met, ExoLabz provides a refund and testing reimbursement, ensuring full research integrity.
Important Legal Disclaimer
For Research Purposes Only
GLP-1/GIP/Glucagon 30mg is intended strictly for scientific research and laboratory investigation. It is not approved by the FDA, Health Canada, or any other regulatory authority. This product is not for human consumption, clinical, therapeutic, or veterinary use.
By purchasing this product, the buyer acknowledges and agrees that it will be used exclusively for lawful laboratory research purposes.
Research Literature
Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.
- Willard FS, et al. JCI Insight. 2020;5(17):e140532. In HEK293 and CHO-K1 cells, measured competition radioligand binding, cAMP accumulation, beta-arrestin recruitment and receptor internalisation at human GIPR and GLP-1R. Source · PMID 32730231
- Zhao F, et al. Nat Commun. 2022;13:1057. Solved five cryo-EM structures of Gs-coupled GIPR, GLP-1R and GCGR at 3.0-3.5 A and measured cAMP potency across site-directed receptor mutants. Source · PMID 35217653
- Knerr PJ, et al. Mol Metab. 2022;63:101533. Rodent study comparing triagonists with tuned GLP-1R/GIPR/GCGR potency ratios; see the linked record for methods and endpoints. Source · PMID 35809773
Literature notes: References concern receptor pharmacology and preclinical models. Clinical literature is outside the scope of this list.
Related Research Compounds
Browse more compounds in Incretin & Glucagon Peptides, or view the full research peptide catalogue.
